Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Advaxis and MedImmune partner on immunotherapy combination trial

July 24, 2014

Biosceptre reports phase I results for BIL-010t in basal cell carcinoma

July 24, 2014

FDA grants breakthrough therapy designation to Aduro's pancreatic cancer combination immunotherapy

July 22, 2014

Mymetics to manufacture Imugene's HER-Vaxx cancer immunotherapy

July 17, 2014

Bristol-Myers Squibb plans Q3 BLA for Opdivo in advanced melanoma

July 11, 2014

Genmab achieves third milestone in daratumumab collaboration

July 9, 2014

Promising phase I data presented for a number of oncolytic immunotherapy candidates

July 8, 2014

Nivolumab, the first drug targeting PD-1 approved

July 7, 2014

Agenus reports final results from phase II study of Prophage in newly diagnosed GBM

July 3, 2014

FDA awards breakthrough therapy designation to blinatumomab in ALL

July 2, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...